Product Description: Rolinsatamab talirine (ABBV 176) is an antibody-drug conjugate (ADC) targeting prolactin receptor (PRLR). Rolinsatamab talirine consists of rolinsatamab (HY-P99238), an enzymatically cleavable peptide linker, and SGD-1882 (HY-101127)[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Mark G Anderson, et al. ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition. BMC Cancer. 2021 Jun 9;21(1):681.
CAS Number: 2095467-44-8
Molecular Weight: N/A
Research Area: Cancer
Target: Drug-Linker Conjugates for ADC